27 January 2023 - US Senator Elizabeth Warren, a Democrat from Massachusetts, and nearly two dozen other lawmakers are demanding to know when the Biden Administration will respond to a languishing 2021 petition by patients with prostate cancer who asked the federal government to intervene to lower the price of enzalutamide, an androgen receptor signalling inhibitor marketed as Xtandi by Pfizer and Japan based Astellas Pharma.

Read The Lancet Oncology [subscription required]